Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of the OncoExTra™...
Stay updated with breaking news from Exact Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of the OncoExTra™...
Influential investor Cathie Wood loaded up on shares of Teladoc Health Inc this week. Here's what she sold off in its place.
The famed money manager's flagship ETF is up 26% in the past month as traders wager that the Fed will ease up on rate hikes as inflation cools.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, supports recent policy changes that help...
Still, he noted "thoughts about their role being diminished in the future is speculative." Esener, who uses gene sequencing machines from Illumina and Pacific Biosciences of California (PacBio) for research looking to detect liver cancer in its earliest stages, noted the field of early cancer detection is diverse, with about 30 companies working on five different methods of testing for signs of very early cancer – including the types Grail and its rivals are focused on. If proven to work, early cancer detection tests could help doctors identify cancer risk in patients long before ...